Parkinson’s Disease

Latest News

Imaging May Predict Parkinson Disease Progression in Older Adults

By

Madeline Morr

Researchers sought to determine the relationship between neuroimaging markers and other clinical characteristics with mild parkinsonian signs in older adults.

The Role of Precision Medicine in Parkinson Disease

By

Amit Akirov, MD

Precision medicine offers a promising therapeutic strategy for patients with Parkinson disease, allowing for tailored treatments which reflect the unique pathophysiology in each patient.

Benefits Seen With Deutetrabenazine in Tardive Dyskinesia Regardless of Age

By

Diana Ernst, RPh

Treatment with deutetrabenazine was found to be beneficial for both younger (<55 years) and older (≥55 years) patients with tardive dyskinesia, according to findings from a recently published post hoc analysis.

Unpacking Parkinson Disease Psychosis: Diagnosis and Treatment

By

S. Hayden Newman, MPAS, PA-C

Lisa Daitch, MPAS, PA-C

Severe neuropsychiatric dysfunction, including psychosis and dementia, is associated with more advanced Parkinson disease.

Tobacco Smoking May Lower Risk for Parkinson Disease While Increasing the Risk of Other Illnesses

By

Brandon May

A study found a causally protective effect of tobacco smoking on the risk of Parkinson disease.

Not Enough Evidence Exists to Support Cannabis for Parkinson Disease

More research is needed to determine the safety and efficacy of cannabis use for the treatment of Parkinson disease symptoms.

Pimavanserin Improves Comorbid Depressive Symptoms in Patients With Parkinson Disease

By

Brandon May

Pimavanserin, either alone or in conjunction with a selective serotonin reuptake inhibitor or serotonin–norepinephrine reuptake inhibitor, may improve comorbid depression symptoms in patients with Parkinson disease.

Patients With Parkinson Disease Report Higher Prevalence of Ophthalmologic Symptoms

By

Brandon May

Compared to the general population, patients with Parkinson disease report a higher prevalence of ophthalmologic symptoms.

Efficacy of Isradipine in Early-Stage Parkinson Disease

By

Amit Akirov, MD

Researchers assessed the effect of isradipine on clinical progression in previously untreated patients with early-stage PD.

How Exercise Affects Sleep Outcomes in Parkinson Disease

By

Amit Akirov, MD

High-intensity exercise training may improve sleep parameters in patients with Parkinson disease.